Literature DB >> 1350243

Sulfasalazine. Multiplicity of action.

T S Gaginella1, R E Walsh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1350243     DOI： 10.1007/bf01300376

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  85 in total

1.  Sulphasalazine and prostaglandin synthesis.

Authors:  C J Hawkey
Journal:  Lancet       Date:  1981-12-12       Impact factor: 79.321

2.  5-Aminosalicylic acid, a co-factor for colonic prostacyclin synthesis?

Authors:  J R Hoult; H Page
Journal:  Lancet       Date:  1981-08-01       Impact factor: 79.321

3.  Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.

Authors:  K M Das; M A Eastwood; J P McManus; W Sircus
Journal:  N Engl J Med       Date:  1973-09-06       Impact factor: 91.245

4.  Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.

Authors:  P Sharon; M Ligumsky; D Rachmilewitz; U Zor
Journal:  Gastroenterology       Date:  1978-10       Impact factor: 22.682

5.  Comparative analysis of systemic immunological parameters in ulcerative colitis and idiopathic proctitis: effects of sulfasalazine in vivo and in vitro.

Authors:  A Rubinstein; K M Das; J Melamed; R A Murphy
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

6.  Determination of prostaglandin synthetase activity in rectal biopsy material and its significance in colonic disease.

Authors:  D W Harris; P R Smith; C H Swan
Journal:  Gut       Date:  1978-10       Impact factor: 23.059

7.  5-Aminosalicylic acid concentration in mucosal interstitium of cat small and large intestine.

Authors:  M B Grisham; D N Granger
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

8.  Prostaglandin synthesis inhibitors in ulcerative colitis: flurbiprofen compared with conventional treatment.

Authors:  D S Rampton; G E Sladen
Journal:  Prostaglandins       Date:  1981-03

9.  4-Aminosalicylic acid, in contrast to 5-aminosalicylic acid, has no effect on arachidonic acid metabolism in human neutrophils, or on the free radical 1,1-diphenyl-2-picrylhydrazyl.

Authors:  O H Nielsen; I Ahnfelt-Rønne
Journal:  Pharmacol Toxicol       Date:  1988-04

10.  Inhibition of neutrophil degranulation and superoxide production by sulfasalazine. Comparison with 5-aminosalicylic acid, sulfapyridine and olsalazine.

Authors:  T M Neal; C C Winterbourn; M C Vissers
Journal:  Biochem Pharmacol       Date:  1987-09-01       Impact factor: 5.858
View more
  10 in total

1.  Sulfasalazine reduces bile acid induced apoptosis in human hepatoma cells and perfused rat livers.

Authors:  C Rust; K Bauchmuller; C Bernt; T Vennegeerts; P Fickert; A Fuchsbichler; U Beuers
Journal:  Gut       Date:  2005-12-01       Impact factor: 23.059

2.  Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease.

Authors:  Rajkumar Malayandi; Phani Krishna Kondamudi; P K Ruby; Deepika Aggarwal
Journal:  Drug Deliv Transl Res       Date:  2014-04       Impact factor: 4.617

3.  Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.

Authors:  C Wahl; S Liptay; G Adler; R M Schmid
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

Review 4.  Comparative tolerability of treatments for inflammatory bowel disease.

Authors:  R B Stein; S B Hanauer
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

5.  Inhibition of nuclear factor kappa B and induction of apoptosis in T-lymphocytes by sulfasalazine.

Authors:  S Liptay; M Bachem; G Häcker; G Adler; K M Debatin; R M Schmid
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

6.  Sulfasalazine reduces inflammatory renal injury in unilateral ureteral obstruction.

Authors:  Savas Demirbilek; Memet Hanefi Emre; Engin Nasuhi Aydin; Mehmet Naci Edali; Rauf Tuğrul Aksoy; Melih Akin; Kubilay Gürünlüoğlu; Erkan Tas; Selma Ay; Zümrüt Yilmaz
Journal:  Pediatr Nephrol       Date:  2007-02-09       Impact factor: 3.714

7.  Hyperbaric oxygen enhances the efficiency of 5-aminosalicylic acid in acetic acid-induced colitis in rats.

Authors:  Semih Gorgulu; Gokhan Yagci; Nihat Kaymakcioglu; Murat Ozkara; Bulent Kurt; Ayhan Ozcan; Omer Kaya; Serdar Sadir; Turgut Tufan
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

8.  Experience with the use of salazosulfapyridine for intractable diarrhea after hematopoietic stem cell transplantation.

Authors:  Naohiko Moriguchi; Sadayuki Isokawa; Atsushi Ando; Hiroshi Miyata
Journal:  Int J Hematol       Date:  2004-12       Impact factor: 2.490

9.  Induction of colitis in rats by 2-2'-azobis(2-amidinopropane) dihydrochloride.

Authors:  H Tamai; S Levin; T S Gaginella
Journal:  Inflammation       Date:  1992-02       Impact factor: 4.092

10.  Sulfasalazine augments a pro-inflammatory response in interleukin-1β-stimulated amniocytes and myocytes.

Authors:  Lynne Sykes; Kacie R Thomson; Emily J Boyce; Yun S Lee; Zahirrah B M Rasheed; David A MacIntyre; Tiong Ghee Teoh; Phillip R Bennett
Journal:  Immunology       Date:  2015-11-03       Impact factor: 7.397
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.